News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Quality of Life with Sotorasib + Panitumumab in KRASG12C-Mutated mCRC – The Lancet Oncology
Logo of The Lancet Oncology from myclinicaloutcomes.com
Aug 15, 2025, 15:50

Quality of Life with Sotorasib + Panitumumab in KRASG12C-Mutated mCRC – The Lancet Oncology

The Lancet Oncology shared a recent study on X by Dominik Paul Modest et al.:

“Health-related quality of life in patients with KRASG12C-mutated chemorefractory metastatic colorectal cancer treated with sotorasib plus panitumumab or standard of care (CodeBreaK 300): results from a phase 3, randomised clinical trial.”

Sotorasib

Title: Health-related quality of life in patients with KRASG12C-mutated chemorefractory metastatic colorectal cancer treated with sotorasib plus panitumumab or standard of care (CodeBreaK 300): results from a phase 3, randomised clinical trial

Journal: The Lancet Oncology

Authors: Dominik Paul Modest, Marwan Fakih, Lisa Salvatore, Taito Esaki, David Páez Lopez-Bravo, Julien Taieb, Michalis Karamouzis, Erika Ruiz-Garcia, Tae Won Kim, Yasutoshi Kuboki, Fausto Meriggi, David Cunningham, Kun-Huei Yeh, Chiara Cremolini, Qui Tran, Emily Chan, Joseph Chao, Istvan Matyas Majer, Filippo Pietrantonio

Read the full article.

Sotorasib

More posts featuring The Lancet Oncology on OncoDaily.

cancer Chiara Cremolini colorectal cancer CRC David Cunningham David Paez Lopez-Bravo Dominik Paul Modest Emily Chan Erika Ruiz-Garcia Fausto Meriggi Filippo Pietrantonio Istvan Matyas Majer Joseph Chao Julien Taieb KRASG12C Kun-Huei Yeh Lisa Salvatore Marwan Fakih Michalis Karamouzis OncoDaily Oncology Panitumumab Qui Tran Sotorasib Tae Won Kim Taito Esaki The Lancet Oncology Yasutoshi Kuboki
Special Coverage
Voices
Aug 15, 2025, 16:00
Amy C Moore Highlights Persistent Challenges in Lung Cancer Survival and Research
Voices
Aug 15, 2025, 15:57
David Heredia Highlighted New Research on Membrane Targets in RET+ NSCLC
Voices
Aug 15, 2025, 15:57
Stephen Liu: Proud to Co-chair The 2026 Texas Lung Cancer Conference with Dr. Tina Cascone
Voices
Aug 15, 2025, 15:57
Minhua Chu: KRAS G12D Inhibitor GFH375 Delivers Strong Responses in NSCLC
Voices
Aug 15, 2025, 15:55
Gender Norms and Barriers Driving Cancer Deaths in West Africa - UICC
Voices
Aug 15, 2025, 15:51
Ruben Mesa: Grateful to Take on a New role as President, Advocate Health Cancer National Service Line
Insight
Aug 15, 2025, 15:50
Quality of Life with Sotorasib + Panitumumab in KRASG12C-Mutated mCRC - The Lancet Oncology
Voices
Aug 15, 2025, 15:48
Annie Wong: Congrats Dr Ros Poulgrain for Presenting New Zealand Clinicians’ Perspective on IO Toxicity Management
Voices
Aug 15, 2025, 15:48
Christopher Fitzmaurice: Study Shows Exercise Benefits in Cancer Surgery Recovery
Voices
Aug 15, 2025, 15:39
Semiramida Nina Markosyan: In Oncology Research, Timing Can Change Everything
Voices
Aug 15, 2025, 15:34
Sabin Motwani: Humbled to be Named an ASTRO Fellow
Insight
Aug 15, 2025, 15:32
Paolo Tarantino: How to Treat Patients with Metastatic Breast Cancer After Prior Exposure to T-DXd?